Burkitt Lymphoma

"Burkitt Lymphoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative.

Descriptor ID	D002051
MeSH Number(s)	C02.256.466.313.165 C02.928.313.165 C04.557.386.480.150.165 C15.604.515.569.480.150.165 C20.683.515.761.480.150.165
Concept/Terms	Burkitt Lymphoma Burkitt Lymphoma Burkitt Leukemia Leukemia, Burkitt Leukemia, Lymphoblastic, Burkitt-Type Burkitt's Lymphoma Burkitts Lymphoma Lymphoma, Burkitt's Burkitt Cell Leukemia Cell Leukemia, Burkitt Leukemia, Burkitt Cell Burkitt's Tumor Burkitts Tumor Tumor, Burkitt's Burkitt Tumor Tumor, Burkitt Leukemia, Lymphocytic, L3 Lymphocytic Leukemia, L3 L3 Lymphocytic Leukemia L3 Lymphocytic Leukemias Leukemia, L3 Lymphocytic Leukemias, L3 Lymphocytic Lymphocytic Leukemias, L3 Burkitt's Leukemia Burkitts Leukemia Leukemia, Burkitt's Lymphoma, Burkitt African Lymphoma African Lymphoma Lymphoma, African

Below are MeSH descriptors whose meaning is more general than "Burkitt Lymphoma".

Diseases [C]
Virus Diseases [C02]
DNA Virus Infections [C02.256]
Herpesviridae Infections [C02.256.466]
Epstein-Barr Virus Infections [C02.256.466.313]
Burkitt Lymphoma [C02.256.466.313.165]
Tumor Virus Infections [C02.928]
Epstein-Barr Virus Infections [C02.928.313]
Burkitt Lymphoma [C02.928.313.165]
Neoplasms [C04]
Neoplasms by Histologic Type [C04.557]
Lymphoma [C04.557.386]
Lymphoma, Non-Hodgkin [C04.557.386.480]
Lymphoma, B-Cell [C04.557.386.480.150]
Burkitt Lymphoma [C04.557.386.480.150.165]
Hemic and Lymphatic Diseases [C15]
Lymphatic Diseases [C15.604]
Lymphoproliferative Disorders [C15.604.515]
Lymphoma [C15.604.515.569]
Lymphoma, Non-Hodgkin [C15.604.515.569.480]
Lymphoma, B-Cell [C15.604.515.569.480.150]
Burkitt Lymphoma [C15.604.515.569.480.150.165]
Immune System Diseases [C20]
Immunoproliferative Disorders [C20.683]
Lymphoproliferative Disorders [C20.683.515]
Lymphoma [C20.683.515.761]
Lymphoma, Non-Hodgkin [C20.683.515.761.480]
Lymphoma, B-Cell [C20.683.515.761.480.150]
Burkitt Lymphoma [C20.683.515.761.480.150.165]

Below are MeSH descriptors whose meaning is related to "Burkitt Lymphoma".

Below are MeSH descriptors whose meaning is more specific than "Burkitt Lymphoma".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Burkitt Lymphoma" by people in this website by year, and whether "Burkitt Lymphoma" was a major or minor topic of these publications.

Bar chart showing 15 publications over 13 distinct years, with a maximum of 2 publications in 1996 and 2006

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	1	2
1997	1	0	1
1998	0	1	1
2004	0	1	1
2006	2	0	2
2007	1	0	1
2009	1	0	1
2016	0	1	1
2017	1	0	1
2018	1	0	1
2019	1	0	1
2021	0	1	1
2023	1	0	1

Below are the most recent publications written about "Burkitt Lymphoma" by people in Profiles.

Burns EA, Wilson JJ, Mathur S, Kieser R, Gong Z, Hu CA, Tang CA, Petkova J, Yuen C, Mai H, Shah S, Rice L, Ganguly S, Pingali SR. Long-term outcomes in patients with Burkitt lymphoma older than 65 years: an analysis of the Texas Cancer Registry. Ann Hematol. 2023 Oct; 102(10):2753-2763.

View in: PubMed
Popay TM, Wang J, Adams CM, Howard GC, Codreanu SG, Sherrod SD, McLean JA, Thomas LR, Lorey SL, Machida YJ, Weissmiller AM, Eischen CM, Liu Q, Tansey WP. MYC regulates ribosome biogenesis and mitochondrial gene expression programs through its interaction with host cell factor-1. Elife. 2021 01 08; 10.

View in: PubMed
Thomas LR, Adams CM, Wang J, Weissmiller AM, Creighton J, Lorey SL, Liu Q, Fesik SW, Eischen CM, Tansey WP. Interaction of the oncoprotein transcription factor MYC with its chromatin cofactor WDR5 is essential for tumor maintenance. Proc Natl Acad Sci U S A. 2019 12 10; 116(50):25260-25268.

View in: PubMed
Wilkie GL, Taggart AA, Prensner JR, Billett AL, Laufer MR. Burkitt Lymphoma Presenting as Menorrhagia and a Vaginal Mass in an Adolescent. J Pediatr Adolesc Gynecol. 2019 Feb; 32(1):90-92.

View in: PubMed
Adams CM, Kim AS, Mitra R, Choi JK, Gong JZ, Eischen CM. BCL-W has a fundamental role in B cell survival and lymphomagenesis. J Clin Invest. 2017 Feb 01; 127(2):635-650.

View in: PubMed
Mattioni J, Portnoy JE, Moore JE, Carlson D, Sataloff RT. Laryngotracheal mucormycosis: Report of a case. Ear Nose Throat J. 2016 Jan; 95(1):29-39.

View in: PubMed
Baker PS, Gold KG, Lane KA, Bilyk JR, Katowitz JA. Orbital burkitt lymphoma in immunocompetent patients: a report of 3 cases and a review of the literature. Ophthalmic Plast Reconstr Surg. 2009 Nov-Dec; 25(6):464-8.

View in: PubMed
Sampson VB, Rong NH, Han J, Yang Q, Aris V, Soteropoulos P, Petrelli NJ, Dunn SP, Krueger LJ. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res. 2007 Oct 15; 67(20):9762-70.

View in: PubMed
Eapen M, Raetz E, Zhang MJ, Muehlenbein C, Devidas M, Abshire T, Billett A, Homans A, Camitta B, Carroll WL, Davies SM. Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research. Blood. 2006 Jun 15; 107(12):4961-7.

View in: PubMed
Gomez-Curet I, Perkins RS, Bennett R, Feidler KL, Dunn SP, Krueger LJ. c-Myc inhibition negatively impacts lymphoma growth. J Pediatr Surg. 2006 Jan; 41(1):207-11; discussion 207-11.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement